The University of Chicago Header Logo

Connection

Aytekin Oto to Image-Guided Biopsy

This is a "connection" page, showing publications Aytekin Oto has written about Image-Guided Biopsy.
Connection Strength

1.052
  1. Navigating the Challenges of Targeting Accuracy and Tumor Heterogeneity in Targeted Prostate Biopsy. Radiology. 2019 Apr; 291(1):90-91.
    View in: PubMed
    Score: 0.164
  2. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer. AJR Am J Roentgenol. 2018 09; 211(3):595-604.
    View in: PubMed
    Score: 0.158
  3. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology. 2017 11; 285(2):343-356.
    View in: PubMed
    Score: 0.150
  4. MRI-guided focal therapy of prostate cancer. Future Oncol. 2017 Mar; 13(6):537-549.
    View in: PubMed
    Score: 0.140
  5. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer. J Urol. 2016 12; 196(6):1670-1675.
    View in: PubMed
    Score: 0.137
  6. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol. 2013 Oct; 64(4):544-52.
    View in: PubMed
    Score: 0.109
  7. Fine-needle aspiration biopsy of thyroid bed lesions in post-thyroidectomy patients: what is the importance of nondiagnostic biopsy results? J Ultrasound Med. 2012 Dec; 31(12):1973-6.
    View in: PubMed
    Score: 0.107
  8. MRI Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2021 12; 217(6):1263-1281.
    View in: PubMed
    Score: 0.049
  9. A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification. JAMA Oncol. 2018 05 01; 4(5):678-685.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.